🇺🇸 FDA
Patent

US 10548916

Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock

granted A61KA61K31/702A61K31/729

Quick answer

US patent 10548916 (Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock) held by DYNEBIO INC. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DYNEBIO INC.
Grant date
Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/702, A61K31/729, A61P, A61P29/00